03:10 PM EDT, 07/28/2025 (MT Newswires) -- CFRA, an independent research provider, has provided MT Newswires with the following research alert. Analysts at CFRA have summarized their opinion as follows:

We lower our 12-month target by $1 to $20, on a forward P/FFO of 10.1x our 2026 FFO estimate, a small discount to DOC's historical forward average of 11.3x, as headwinds in the Lab industry persist while Outpatient Medical rental growth slows. We retain our 2025 FFO estimate at $1.86 and lower 2026's by $0.03 to $1.98. Management provided a detailed breakdown of Lab occupancy trends: one-third of tenants are expanding footprints, one-third facing natural lease expiration/renewal, and one-third are distressed departures. DOC's primary concerns within the Lab segment remain the oversupply of space mixed with tighter financial conditions impacting capital raising efforts for tenants. We note that re-leasing spreads improved Q/Q in Outpatient Medical and see this segment driving long-term NOI growth as supply remains at 20-year lows with an aging population. Proposed CMS rule changes reversing the inpatient-only list would make outpatient the default, providing more choice and benefiting DOC outpatient centers.